Vernalis (R&D) Ltd, Granta Park, Cambridge CB21 6GB, UK.
Bioorg Med Chem Lett. 2012 Jan 15;22(2):901-6. doi: 10.1016/j.bmcl.2011.12.032. Epub 2011 Dec 13.
We describe here our attempts to optimise the human fatty acid amide hydrolase (FAAH) inhibition and physicochemical properties of our previously reported tetrasubstituted azetidine urea FAAH inhibitor, VER-156084. We describe the SAR of a series of analogues and conclude with the demonstration of in vivo dose-dependant FAAH inhibition in an anandamide-loading study in rats.
我们在此描述了优化先前报道的四取代氮杂环丁烷脲 FAAH 抑制剂 VER-156084 的人类脂肪酸酰胺水解酶 (FAAH) 抑制作用和理化性质的尝试。我们描述了一系列类似物的 SAR,并在大鼠中进行的大麻素加载研究中证明了体内剂量依赖性 FAAH 抑制作用。